<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Excretion of <z:chebi fb="2" ids="18095">hydroxyproline</z:chebi> with urine was studied in 16 children with localized form of <z:hpo ids='HP_0000767'>funnel chest</z:hpo> deformation simultaneously with Marfan and <z:e sem="disease" ids="C0013720" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Ehlers-Danlos syndromes</z:e>, in 9 children with the localized form of deformation within 6-8 months after thorax surgical plastic operation as well as in 3 children with <z:e sem="disease" ids="C0013720" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Ehlers-Danlos syndrome</z:e> but without <z:hpo ids='HP_0000767'>funnel chest</z:hpo> deformation </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000767'>Funnel chest</z:hpo> deformation of the II-III degree, independently of its form, was accompanied by a decrease of total <z:chebi fb="2" ids="18095">hydroxyproline</z:chebi> in urine as compared with healthy children of the similar age </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:chebi fb="2" ids="18095">hydroxyproline</z:chebi> excretion was normalized after thoracoplastic operation in the children with localized form of the chest deformation </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:e sem="disease" ids="C0013720" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Ehlers-Danlos syndrome</z:e>, independently on presence or absence of the chest deformation, relative content of free <z:chebi fb="2" ids="18095">hydroxyproline</z:chebi> was increased in urine, while the <z:chebi fb="7" ids="16670">peptide</z:chebi>-bound amino acid was decreased (<z:chebi fb="7" ids="16670">peptides</z:chebi> with molecular mass above 700 daltons); this phenomenon appears to be a characteristic property of the syndrome </plain></SENT>
</text></document>